Vice President, Market Access, HEOR and Patient Services - Radiopharma

Job Description Summary Our business purpose: We are a purpose-driven team working to drive life-changing clarity in precision diagnostics that helps uncover what’s hidden inside the body – enabling earlier, more confident decisions in the fight against diseases like Alzheimer's, cardiovascular conditions, and cancer. As part of a company that delivers both radiopharmaceutical doses and the PET imaging infrastructure needed to use them, we play a critical role in expanding access to precision diagnostics – for providers, for systems, and most importantly, for patients. What sets us apart is a combination of unmatched clinical expertise, unwavering commitment to advancing science, as well as our deep commitment to showing up with urgency, care, and empathy – helping more people move from uncertainty to understanding. We believe that behind every scan is a heartbeat and behind every heartbeat is a story, and we treat each one like it matters – because lives are shaped in moments like these. Who thrives here: You’ll thrive here if you care deeply – about your teammates, about the people we serve, and about doing what’s right, even when it’s hard. You bring both heart and discipline to your work, with a curiosity to uncover what customers truly need and the courage to make tough calls when clarity is elusive. This is a space where ambiguity is real, decisions carry weight, and collaboration isn’t optional – it’s how we move forward. If you find meaning in building something that matters and supporting others while doing it, you’ll feel at home here. GE HealthCare ’s US Radiopharma business is seeking Executive, Market Access, HEOR and Patient services to lead the market access strategy for a growing portfolio of molecular imagine and radiopharmaceutical products across cardiology, neurology and oncology. Job Description This role will be responsible for leading US market access strategies across payer access, reimbursement policy, CMS and Medicaid strategy, HEOR, covera